Single Ascending Dose, First-in-Human Study on Safety, Tolerability and Pharmacokinetics of BAY1161116
Clinical trial NCT03119077 · TERMINATED
Trial details
- NCT number
- NCT03119077
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-27
- Primary completion
- 2017-09-08
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.